Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6167286rdf:typepubmed:Citationlld:pubmed
pubmed-article:6167286lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:6167286lifeskim:mentionsumls-concept:C0677626lld:lifeskim
pubmed-article:6167286lifeskim:mentionsumls-concept:C0041487lld:lifeskim
pubmed-article:6167286lifeskim:mentionsumls-concept:C0042010lld:lifeskim
pubmed-article:6167286lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:6167286lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:6167286lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:6167286lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:6167286lifeskim:mentionsumls-concept:C0049192lld:lifeskim
pubmed-article:6167286pubmed:issue1lld:pubmed
pubmed-article:6167286pubmed:dateCreated1981-10-29lld:pubmed
pubmed-article:6167286pubmed:abstractTextHepatoma tissue culture cells, grown in the presence of D-galactosamine and 6-azauridine, demonstrate a strong reduction of the intracellular UTP pool that can be replenished by formation of UTP from uridine and FUTP from 5-fluorouridine within 2 h. Concomitantly with the UTP deficiency, a decrease of dexamethasone-induced tyrosine aminotransferase activity occurs. 5-Fluorouridine, as compared to uridine, is even more efficient in restoring the activity of tyrosine aminotransferase. Treatment of the cells with D-galactosamine alone results in a minor lowering of UTP that is not followed by the inhibition of the enzyme induction. However, the administration of D-galactosamine, simultaneously or at any time up to 5 h before or after dexamethasone, leads to a 1.5- to 2-fold higher induction (superinduction) which appears 24 h later.lld:pubmed
pubmed-article:6167286pubmed:languageenglld:pubmed
pubmed-article:6167286pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167286pubmed:citationSubsetIMlld:pubmed
pubmed-article:6167286pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167286pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167286pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167286pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167286pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167286pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167286pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167286pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6167286pubmed:statusMEDLINElld:pubmed
pubmed-article:6167286pubmed:monthAuglld:pubmed
pubmed-article:6167286pubmed:issn0006-3002lld:pubmed
pubmed-article:6167286pubmed:authorpubmed-author:BeckGGlld:pubmed
pubmed-article:6167286pubmed:authorpubmed-author:KepplerD ODOlld:pubmed
pubmed-article:6167286pubmed:authorpubmed-author:HolstegeAAlld:pubmed
pubmed-article:6167286pubmed:authorpubmed-author:GiesenE MEMlld:pubmed
pubmed-article:6167286pubmed:issnTypePrintlld:pubmed
pubmed-article:6167286pubmed:day27lld:pubmed
pubmed-article:6167286pubmed:volume655lld:pubmed
pubmed-article:6167286pubmed:ownerNLMlld:pubmed
pubmed-article:6167286pubmed:authorsCompleteYlld:pubmed
pubmed-article:6167286pubmed:pagination34-40lld:pubmed
pubmed-article:6167286pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6167286pubmed:meshHeadingpubmed-meshheading:6167286-...lld:pubmed
pubmed-article:6167286pubmed:meshHeadingpubmed-meshheading:6167286-...lld:pubmed
pubmed-article:6167286pubmed:meshHeadingpubmed-meshheading:6167286-...lld:pubmed
pubmed-article:6167286pubmed:meshHeadingpubmed-meshheading:6167286-...lld:pubmed
pubmed-article:6167286pubmed:meshHeadingpubmed-meshheading:6167286-...lld:pubmed
pubmed-article:6167286pubmed:meshHeadingpubmed-meshheading:6167286-...lld:pubmed
pubmed-article:6167286pubmed:meshHeadingpubmed-meshheading:6167286-...lld:pubmed
pubmed-article:6167286pubmed:meshHeadingpubmed-meshheading:6167286-...lld:pubmed
pubmed-article:6167286pubmed:meshHeadingpubmed-meshheading:6167286-...lld:pubmed
pubmed-article:6167286pubmed:meshHeadingpubmed-meshheading:6167286-...lld:pubmed
pubmed-article:6167286pubmed:meshHeadingpubmed-meshheading:6167286-...lld:pubmed
pubmed-article:6167286pubmed:year1981lld:pubmed
pubmed-article:6167286pubmed:articleTitleInhibition of tyrosine aminotransferase induction by UTP deficiency and its reversal by 5-fluorouridine in cultured hepatoma cells.lld:pubmed
pubmed-article:6167286pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6167286pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed